Chinese regulators slap J&J and rivals with a price-fixing fine; Indian court agrees to hear Teva's patent appeal;

@FiercePharma: ICYMI yesterday: The top 10 best-selling vaccines of 2013. Report | Follow @FiercePharma

@TracyStaton: ICYMI, FiercePharma's top weekend news: FDA-nixed diabetes med from Lilly, Boehringer faces rough path to stardom. More | Follow @TracyStaton

@CarlyHFierce: Study: Moral concerns lead barriers to Gardasil uptake in college freshmen. Story from FierceVaccines | Follow @CarlyHFierce

> Chinese regulators slapped Johnson & Johnson ($JNJ), Bausch & Lomb and rivals with a combined 19.6 million yuan (about $3 million) fine for price fixing in the country's contact lens and eyeglass market. Story

> The Delhi High Court agreed to hear Teva's ($TEVA) appeal against Natco Pharma in the companies' ongoing patent infringement case. More

> Bayer received the European Commission's OK to expand approved uses for its thyroid cancer drug Nexavar. Article

> A low dose of antidepressants could provide an alternative treatment for hot flashes in menopausal woman, according to new study results published in JAMA Internal Medicine. More

> The numbers of drugs prescribed for alcoholism in England jumped 79% in the last decade. Item

> Dutch researchers say combining medications to treat symptoms of asthma may be more effective than using one drug. Story

> Zydus kicked off Phase III trials of its LipaGlyn drug for patients with lipodystrophy . Release

Medical Device News

@FierceMedDev: Qiagen and Lilly continue successful string of diagnostics partnerships. More | Follow @FierceMedDev

@VarunSaxena2: Medicare will next year have 140,000 different codes, including nine for injuries caused by turkeys. Story from The Economist | Follow @VarunSaxena2

@MichaelGFierce: 'Nanodaisies' carry two cancer drugs and protect them in the bloodstream. Article | Follow @MichaelGFierce

@EmilyWFierce: FDA will hear Sanofi's second plea for Lemtrada approval. Item | Follow @EmilyWFierce

> Globus Medical unveils new 'self-locking' spinal implant device. Story

> Samsung says its software and hardware will power the digital health ecosystem. More

Biotech News

@FierceBiotech: AbbVie heralds early success with its brain cancer-fighting armed antibody. Story | Follow @FierceBiotech

@JohnCFierce: I have to admit, every time I hear something about 'dendritic cells,' I cringe a little. #ASCO14 | Follow @JohnCFierce

@DamianFierce: FT's "usually well informed sources" say $SHPG is eyeing $NPSP. More | Follow @DamianFierce

@EmilyMFierce: BMJ accuses EMA of watering down open trial data policy. Story | Follow @EmilyMFierce

> Can AstraZeneca's cancer pipeline come through on a $12B promise? Story

> Metabolic disease, cardio expert joins Pfizer's R&D team. Chutes & Ladders

And Finally... Richard III suffered from scoliosis, not a hunchback, say researchers at the University of Leicester. More

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.